BI
Bioelectronics Corporation
BIEL · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $7.41M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 14.94x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 32.45%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 79.17%
Gross margin 73.32%
FCF margin 33.09%
Quality
79 /100
Excellent Asset turnover 11.45x
ROIC 20.93%
ROA 2,148.02%
Debt
0 /100
High Int. coverage -0.73x
Current ratio 0.01x
Debt/Assets N/A
Stability
15 /100
Unstable Profitable years 0
Beta 2.05x
Rev. volatility 28.59%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BIEL
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Kelly A. Whelan
Employees
9
Headquarters
Frederick